Here are the DEF 14A proxy statements from Immuneering Corporation (IMRX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow IMRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMRX filings page.
Immuneering Corporation is holding a virtual 2026 annual stockholder meeting on June 11, 2026 at 11:00 a.m. Eastern Time. Stockholders will vote on electing two Class II directors, Peter Feinberg and Laurie B. Keating, to terms running to the 2029 annual meeting, and on ratifying RSM US LLP as independent registered public accounting firm for the year ending December 31, 2026. Holders of 64,697,227 outstanding shares of Class A common stock as of April 15, 2026 are entitled to one vote per share and may vote by internet, telephone, mail, or during the live webcast.